tirzepatide compounding pharmacy san diego Tirzepatide Zepbound® University Compounding Pharmacy

Once weekly tirzepatide and treatment exposure of up to 104 weeks (median follow-up of 55 weeks) resulted in an HR of 0.81 (97.85% CI, 0.521.26) for the pooled tirzepatide group compared to the pooled comparator group from 116 composite MACE-4 endpoints (pooled tirzepatide: 60 (1.37 per 100 person-years) and pooled comparator: 56 (1.60 per 100 person-years)) and, therefore, met the criteria that treatment with tirzepatide was not associated with excess cardiovascular risk and initiated early close-out of SURPASS-4

We see the metabolic benefits of this dual agonism reflected in lower blood sugar, stabilized insulin levels, and reduced hunger

Retatrutide may, in time, receive regulatory approval and become a valuable addition to the weight management toolkit

It requires careful monitoring to ensure that you are still consuming enough nutrients and staying hydrated as your appetite significantly decreases